摘要
目的:观察复方甘草酸苷治疗药物性肝病的疗效。方法:将158例药物性肝病的患者随机分成治疗组(80例)和对照组(78例),治疗组在对照组用药基础上加用复方甘草酸苷,治疗结束后进行疗效分析。结果:两组患者症状、体征的恢复无显著性差异,但在丙氮酸氨基转移酶(ALT)、天门冬氨酸氨基转移酶(AST)、总胆红素(TBIL)的恢复速度上均明显优于对照组(P<0.01)。结论:复方甘草酸苷用于药物性肝病效果明显,用药安全,值得推荐。
OBJECTIVE: To observe the clinical effects of Stronger Neo-Minophagen C(SNMC) in the treatment of drug induced liver disease. METHODS:108 patients of drug induced liver disease were randomly divided into treatment group(80 cases) and control group (78 cases). SNMC injection was given in the treatment group as a supplement to the primary therapy given in the control group. RESULTS: The treatment group with SNMC showed significantly greater improvement than the control group in the liver functions(ALT. AST,TBIL)(P<0.01), but there was no significant difference in symptoms recover. CONCLUSION:SNMC is a secure medicine with less side effects and therefore is recommendable for treatment of drug induced liver disease.
出处
《中国处方药》
2005年第8期78-79,共2页
Journal of China Prescription Drug
